Clearbridge Investments, LLC Vertex Pharmaceuticals Inc Transaction History

Clearbridge Investments, LLC

$119 Billion
Q2 2024

A detailed history of Clearbridge Investments, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Clearbridge Investments, LLC holds 2,090,704 shares of VRTX stock, worth $1.02 Billion. This represents 0.82% of its overall portfolio holdings.

Number of Shares

2,090,704

Previous 2,090,704 -0.0%

Holding current value

$1.02 Billion

Previous $980 Million -0.0%

% of portfolio

0.82%

Previous 0.82%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $133 Million - $164 Million	-337,751 Reduced 13.91%	2,090,704 $980 Million
Q1 2024 May 13, 2024	SELL	$407.69 - $446.08 $66.9 Million - $73.2 Million	-164,120 Reduced 6.33%	2,428,455 $1.02 Billion
Q4 2023 Feb 09, 2024	SELL	$343.0 - $410.68 $120 Million - $144 Million	-350,609 Reduced 11.91%	2,592,575 $1.05 Billion
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $70.4 Million - $75.5 Million	-208,238 Reduced 6.61%	2,943,184 $1.02 Billion
Q2 2023 Aug 11, 2023	SELL	$314.42 - $351.91 $58.6 Million - $65.6 Million	-186,319 Reduced 5.58%	3,151,422 $1.11 Billion
Q1 2023 May 12, 2023	SELL	$283.23 - $323.1 $42 Million - $47.9 Million	-148,379 Reduced 4.26%	3,337,741 $1.05 Billion
Q4 2022 Feb 10, 2023	SELL	$285.76 - $321.48 $119 Million - $133 Million	-414,736 Reduced 10.63%	3,486,120 $1.01 Billion
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $93.8 Million - $105 Million	-342,408 Reduced 8.07%	3,900,856 $1.13 Billion
Q2 2022 Aug 11, 2022	SELL	$234.96 - $292.55 $214 Million - $266 Million	-909,488 Reduced 17.65%	4,243,264 $1.2 Billion
Q1 2022 May 13, 2022	SELL	$221.42 - $260.97 $9.74 Million - $11.5 Million	-43,978 Reduced 0.85%	5,152,752 $1.34 Billion
Q4 2021 Feb 11, 2022	BUY	$177.01 - $223.45 $14.9 Million - $18.8 Million	84,326 Added 1.65%	5,196,730 $1.14 Billion
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $23.5 Million - $26.4 Million	129,810 Added 2.61%	5,112,404 $927 Million
Q2 2021 Aug 13, 2021	SELL	$187.49 - $221.1 $101 Million - $119 Million	-538,616 Reduced 9.76%	4,982,594 $1 Billion
Q1 2021 May 13, 2021	BUY	$207.02 - $241.31 $258 Million - $300 Million	1,244,784 Added 29.11%	5,521,210 $1.19 Billion
Q4 2020 Feb 10, 2021	SELL	$207.01 - $276.09 $40.3 Million - $53.8 Million	-194,854 Reduced 4.36%	4,276,426 $1.01 Billion
Q3 2020 Nov 12, 2020	BUY	$255.65 - $303.1 $77.8 Million - $92.2 Million	304,248 Added 7.3%	4,471,280 $1.22 Billion
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $73.5 Million - $96.4 Million	325,938 Added 8.49%	4,167,032 $1.21 Billion
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $56.7 Million - $70.3 Million	-283,619 Reduced 6.88%	3,841,094 $914 Million
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $149 Million - $200 Million	-891,172 Reduced 17.77%	4,124,713 $905 Million
Q3 2019 Nov 14, 2019	SELL	$166.23 - $187.09 $26.9 Million - $30.3 Million	-161,981 Reduced 3.13%	5,015,885 $850 Million
Q2 2019 Aug 14, 2019	SELL	$164.61 - $190.37 $22.5 Million - $26.1 Million	-136,839 Reduced 2.57%	5,177,866 $0
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $27.6 Million - $32.8 Million	-168,447 Reduced 3.07%	5,314,705 $978 Million
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $9.54 Million - $12.1 Million	-62,814 Reduced 1.13%	5,483,152 $909 Million
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $76.2 Million - $87.6 Million	-454,501 Reduced 7.57%	5,545,966 $1.07 Billion
Q2 2018 Aug 14, 2018	SELL	$145.72 - $169.96 $56.9 Million - $66.3 Million	-390,259 Reduced 6.11%	6,000,467 $1.02 Billion
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $44.7 Million - $52.2 Million	-294,943 Reduced 4.41%	6,390,726 $1.04 Billion
Q4 2017 Feb 14, 2018	SELL	$137.28 - $155.55 $54.2 Million - $61.4 Million	-394,502 Reduced 5.57%	6,685,669 $1 Billion
Q3 2017 Nov 14, 2017	SELL	$148.13 - $162.24 $124 Million - $136 Million	-838,582 Reduced 10.59%	7,080,171 $1.08 Billion
Q2 2017 Aug 14, 2017	BUY	N/A	7,918,753	7,918,753 $1.02 Billion

Others Institutions Holding VRTX

# of Institutions

1,707

Shares Held

226M

Call Options Held

1.2M

Put Options Held

1.59M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $125B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.

Account

Clearbridge Investments, LLC Vertex Pharmaceuticals Inc Transaction History